We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:GTBP

GT Biopharma (GTBP)

Nasdaq • GTBP • US36254L4077

3.95Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Oct 28, 2026, ORTEX estimated 17.5% of free float sold short, 4.5 days to cover, cost to borrow 309.88%. Sign up for live short interest data.

Market Cap

7.11m USD | # 11582 in US

Volume

71.26k shares | 465.87k USD

Shares Outstanding

1.8m

Free Float Shares

85.64% | 1.55m

News

GTBP key data

GT Biopharma (Nasdaq: GTBP) has a market capitalization of $7.11M. Last close $3.95 (as of 2026-11-12); 52-week range $3.86 to $28.75. ORTEX data as of 2026-10-28: short interest was 17.45% of free float, 4.5 days to cover and the average cost to borrow was 309.88%. Sign up for live short interest data.

GTBP news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.